BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7432099)

  • 1. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra.
    Fadda F; Argiolas A; Melis MR; Serra G; Gessa GL
    Life Sci; 1980 Sep; 27(11):979-86. PubMed ID: 7432099
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acute and chronic ethanol on dopamine synthesis in the caudate nucleus, substantia nigra and frontal cortex.
    Fadda F; Argiolas A; Melis MR; Serra G
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2553-8. PubMed ID: 7470302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol on the metabolism of regional brain dopamine.
    Fadda F; Argiolas A; Melis MR; Serra G; Congia S
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2559-63. PubMed ID: 7470303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Serra G; Gessa GL
    Brain Res; 1979 Oct; 175(1):178-82. PubMed ID: 487148
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.
    Pericić D; Walters JR
    J Pharm Pharmacol; 1976 Jun; 28(6):527-30. PubMed ID: 7658
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F; Argiolas A; Stefanini E; Gessa GL
    Life Sci; 1977 Aug; 21(3):411-7. PubMed ID: 895373
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--II. Studies using ibotenic acid injection of the parafascicular-intralaminar nuclei.
    Kilpatrick IC; Jones MW; Johnson BJ; Cornwall J; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):979-90. PubMed ID: 3796824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    Brain Res; 1974 Mar; 68(2):253-60. PubMed ID: 4826898
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of dopamine in the ventral tegmental area of rat.
    Fadda F; Melis MR; Argiolas A; Perra G
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V
    Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K; Shibata R
    Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G; Saiani L; Spano PF; Trabucchi M
    Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization.
    Kilpatrick IC; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine, a modulator of carbohydrate metabolism in the caudate nucleus.
    Anchors JM; Garcia-Rill E
    Brain Res; 1977 Sep; 133(1):183-9. PubMed ID: 902086
    [No Abstract]   [Full Text] [Related]  

  • 20. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
    Constantinidis J; Bartholini G; Tissot R; Pletscher A
    Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.